Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $476.43 million. The enterprise value is $278.24 million.

Market Cap	476.43M
Enterprise Value	278.24M

Important Dates

The last earnings date was Wednesday, February 12, 2025, before market open.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

MLYS has 49.84 million shares outstanding. The number of shares has increased by 34.13% in one year.

Current Share Class	49.84M
Shares Outstanding	49.84M
Shares Change (YoY)	+34.13%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	2.53%
Owned by Institutions (%)	58.77%
Float	27.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.49
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.02

Current Ratio	14.02
Quick Ratio	13.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -82.24% and return on invested capital (ROIC) is -55.62%.

Return on Equity (ROE)	-82.24%
Return on Assets (ROA)	-52.56%
Return on Invested Capital (ROIC)	-55.62%
Return on Capital Employed (ROCE)	-100.60%
Revenue Per Employee	n/a
Profits Per Employee	-$6.35M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.52% in the last 52 weeks. The beta is 1.45, so MLYS's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-37.52%
50-Day Moving Average	10.96
200-Day Moving Average	12.23
Relative Strength Index (RSI)	42.42
Average Volume (20 Days)	292,047

Short Selling Information

The latest short interest is 1.86 million, so 3.74% of the outstanding shares have been sold short.

Short Interest	1.86M
Short Previous Month	1.87M
Short % of Shares Out	3.74%
Short % of Float	6.87%
Short Ratio (days to cover)	7.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-192.40M
Pretax Income	-90.80M
Net Income	-177.81M
EBITDA	-192.36M
EBIT	-192.40M
Earnings Per Share (EPS)	-$3.66

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	198.19M
Total Debt	n/a
Net Cash	198.19M
Net Cash Per Share	$3.98
Equity (Book Value)	191.26M
Book Value Per Share	3.84
Working Capital	190.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$166.31 million and capital expenditures -$96,000, giving a free cash flow of -$166.41 million.

Operating Cash Flow	-166.31M
Capital Expenditures	-96,000
Free Cash Flow	-166.41M
FCF Per Share	-$3.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.13%
Shareholder Yield	-34.13%
Earnings Yield	-37.32%
FCF Yield	-34.93%

Analyst Forecast

The average price target for MLYS is $27.00, which is 182.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$27.00
Price Target Difference	182.43%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1